Effector Therapeutics Inc (EFTR) Annual Balance Sheets

Annual · GAAP · USD millions
Access EFTR quarterly Balance Sheets →
The data below summarizes Effector Therapeutics Inc's balance sheet position from to Dec 31 2023, enabling a period-by-period comparison of financial strength.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2023)
(Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent14.88
Short-term Investments, Total3.50
Cash & Short-term Investments17.00
Prepaid Expense And Other Assets Current1.47
Total Current Assets19.84
Equipment/Property/Plant Net0.14
Other Assets, Noncurrent0.57
Operating Lease Right Of Use Asset0.05
Total Assets20.54
Liabilities
Accounts Payable, Current AC2.33
Accrued Liabilities, Current AC2.92
Other Liabilities, Current20.55
Total Current Liabilities25.80
Total Long-term Debt0.00
Other liabilities, Noncurrent0.54
Term Loans Net19.39
Earn Out Liability-
Operating Lease Liability Current0.06
Total Liabilities26.34
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock173.58
Retained Earnings / Accumulated Deficit-179.38
Defined Benefit Plan and Other0.00
Other Equity0.00
Common Stockholder's Equity-5.80
Total Stockholder's Equity-5.80
Liabilities & Stockholder's Equity20.54
4 historic quarters locked

Sign in to unlock the full Effector Therapeutics Inc balance sheet history.

About Effector Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-036169

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License